Home Pilots Abbott’s implantable cardiac monitor CardioMEMS lands expanded FDA designation Pilots Abbott’s implantable cardiac monitor CardioMEMS lands expanded FDA designation By - February 22, 2022 101 0 Facebook Twitter Pinterest WhatsApp The system first landed clearance in 2014 for Class III heart failure patients. RELATED ARTICLESMORE FROM AUTHOR Pilots Former Ripple exec Greg Kidd buys Know Labs with Bitcoin Pilots RadNet acquires See-Mode Technologies for access, revenue growth Pilots FDA launches AI tool for its employees LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Icon Group enters AI radiology research partnership with Varian Pilots - May 6, 2022 0 Portal Access secures $7M for chemotherapy port Pilots - May 30, 2025 0 Vial raises $67M for clinical trial tech and more digital health fundings Pilots - December 5, 2022 0 Endoluminal robotics company EndoQuest scores $42M Pilots - December 4, 2023 0 Auxira Health launches virtual cardiology model Pilots - May 22, 2025 0 POPULAR CATEGORIESPilots2369Applications835Testing285Collaborations15GitHub3